Comparative evaluation of immunogenicity and reactogenicity of bivalent oral poliovirus vaccine (bOPV) and trivalent oral poliovirus vaccine (tOPV) in the standard EPI schedule, with or without inactivated polio vaccine (IPV) administration at DTP3 contact: A randomized controlled trial - WHO EPI Study
Latest Information Update: 03 Jul 2019
At a glance
- Drugs Poliovirus vaccine live oral (Primary) ; Poliovirus vaccine inactivated
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Acronyms WHO EPI
- Sponsors Panacea Biotec
- 28 Apr 2014 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 05 Jul 2013 New trial record